Anthropic’s June 2026 launches of Claude Fable 5 (public, safeguarded) and Claude Mythos 5 (restricted) established the Mythos-class tier above Opus, with roughly 5–8 trillion parameters and strong agentic capabilities. Trader sentiment now centers on whether Anthropic’s internal Model 2, which reportedly outperforms Mythos 5 on key benchmarks, reaches public release before competitors such as OpenAI or Google DeepMind ship equivalent frontier systems. Safety concerns around cybersecurity and bioweapon risks, plus the company’s IPO timeline, continue to influence rollout pace, while upcoming developer conferences and earnings calls could surface new capability demonstrations or partnership details that shift market-implied odds.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedNext Mythos-Class Model released by…?
$142,140 Vol.
August 31
28%
September 15
70%
September 30
78%
$142,140 Vol.
August 31
28%
September 15
70%
September 30
78%
This market will resolve to "Yes" if Anthropic releases the next Mythos-class model and makes it available to the general public by the listed date (ET). Otherwise, this market will resolve to "No."
Any model whose official name includes “Mythos,” or that Anthropic officially describes as a “Mythos-class” model or similar, will qualify for this market’s resolution.
For this market to resolve to "Yes," the qualifying model (as defined above) must be launched and publicly accessible, including via open beta or open rolling waitlist signups. A closed beta or any form of private access will not suffice. The release must be clearly defined and publicly announced by Anthropic as being accessible to the general public.
If a qualifying model is made publicly accessible and labeled with the relevant version name within the company’s official website, this will qualify as “publicly announced”. Labeling errors, placeholder text, or version names displayed on the website that do not correspond to a model that is actually accessible to the general public under the rules will not qualify.
The primary resolution source for this market will be official information from Anthropic; however, a consensus of credible reporting will also be used.
Market Opened: Aug 6, 2026, 9:37 AM ET
Resolver
0x65070BE91...This market will resolve to "Yes" if Anthropic releases the next Mythos-class model and makes it available to the general public by the listed date (ET). Otherwise, this market will resolve to "No."
Any model whose official name includes “Mythos,” or that Anthropic officially describes as a “Mythos-class” model or similar, will qualify for this market’s resolution.
For this market to resolve to "Yes," the qualifying model (as defined above) must be launched and publicly accessible, including via open beta or open rolling waitlist signups. A closed beta or any form of private access will not suffice. The release must be clearly defined and publicly announced by Anthropic as being accessible to the general public.
If a qualifying model is made publicly accessible and labeled with the relevant version name within the company’s official website, this will qualify as “publicly announced”. Labeling errors, placeholder text, or version names displayed on the website that do not correspond to a model that is actually accessible to the general public under the rules will not qualify.
The primary resolution source for this market will be official information from Anthropic; however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Anthropic’s June 2026 launches of Claude Fable 5 (public, safeguarded) and Claude Mythos 5 (restricted) established the Mythos-class tier above Opus, with roughly 5–8 trillion parameters and strong agentic capabilities. Trader sentiment now centers on whether Anthropic’s internal Model 2, which reportedly outperforms Mythos 5 on key benchmarks, reaches public release before competitors such as OpenAI or Google DeepMind ship equivalent frontier systems. Safety concerns around cybersecurity and bioweapon risks, plus the company’s IPO timeline, continue to influence rollout pace, while upcoming developer conferences and earnings calls could surface new capability demonstrations or partnership details that shift market-implied odds.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated
Beware of external links.
Beware of external links.
Frequently Asked Questions